| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.095 | 0.7 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |